Respiratory inhaler is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation.
It is the most commonly used medication delivery system for treating Asthma, Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Whereas, COPD is the obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD. The primary cause of COPD is tobacco smoke (through tobacco use or second-hand smoke).
As per WHO, Some 235 million people currently suffer from asthma and more than 3 million people died of COPD in 2012, which is equal to 6% of all deaths globally that year.
Browse Full Report@ http://www.futuremarketinsights.com/reports/respiratory-inhaler-devices-market
Respiratory Inhaler Devices Market: Drivers and Restraints
The respiratory inhaler devices market is driven by aging population and increasing respiratory disease among global population.
Respiratory inhaler devices market will be driven by new technological advancements. The huge population afflicted with respiratory disorders such as asthma and chronic obstructive pulmonary disease will drive the Respiratory inhaler market. Increasing focus among pediatric patients with COPD and Asthma. Also, awareness programmes by healthcare organization to increase adoption rate will drive this market. However, it is observed that the respiratory inhalers, particularly Metered Dose Inhaler (MDIs), release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is acting as a barrier in the adoption of such devices.
Respiratory Inhaler Devices Market: Segmentation
The global respiratory inhaler devices market is segmented into following devices:
- Dry Powder Inhalers
- Metered Dose Inhaler
- Nebulizers
Considering the growth and market size, Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and is expected to grow at a higher rate in the forecast period.
Respiratory Inhaler Devices Market: Overview
With rapid technological advancement and wide acceptance of respiratory inhaler devices among patients with respiratory disorder, the global respiratory inhaler market is expected to grow at a healthy CAGR of around 8% in the forecast period (2015-2025).
Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-493
Respiratory Inhaler Devices Market: Regional Outlook
The global respiratory inhaler devices market is expected to register a significant growth for the forecast period. Depending on geographic regions, the global respiratory inhaler devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America is the largest market for respiratory inhaler devices, followed by Europe and Asia. North America and Europe has a well-established pharmaceutical industry, which has stimulated the growth of the respiratory inhaler device market in these regions. The Asian market is expected to witness a double digit growth over the next five years, owing to the flourishing pharmaceutical industry, development of healthcare infrastructure, and rising disposable income.
Respiratory Inhaler Devices Market: Key Players
GlaxoSmithKline plc., Boehringer Ingelheim GmbH, AstraZeneca plc., Hospira Inc., Care Fusion Corporation, 3M Company are some of the major key players in Respiratory Inhaler devices global market.
